SMTI Stock Analysis: Buy, Sell, or Hold?
SMTI - Sanara MedTech Inc. Common Stock
$34.07
0.07 (0.21%)
▲
5d:
+27.89%
30d:
+35.36%
90d:
+79.41%
WAIT
LOW Confidence
Analysis Updated: Aug 3, 2026 12:00 AM ET
Earnings: Aug 12, 2026
7d
Get Alerted When SMTI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: SMTI is 24.7% above its trading range ($27.33). Market expects 20.2% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: SMTI is 24.7% above its trading range ($27.33). Market expects 20.2% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$26.29
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$16.32
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SMTI is currently trading at $34.07, which is considered extended relative to its 30-day fair value range of $22.65 to $27.33. From a valuation perspective, the stock is trading at a premium (Forward PE: 63.0) compared to its historical average (36.3). At these levels, the market is pricing in 20.2% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, SMTI is in a strong uptrend. The price is approaching resistance at $34.33. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: SMTI has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SMTI is in a strong uptrend. The price is approaching resistance at $34.33. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: SMTI has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$22.65 -
$27.33
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
46.7%
All Signals
- BEARISH: Price significantly overextended (+24.7% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($35.00)
- NEUTRAL: Trading at premium valuation - market expects 20.2% growth which is achievable
- WARNING: Recommendation downgraded due to 24.7% overvaluation
Trading Range Analysis
30-Day Trading Range
$22.65 -
$27.33
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$24.77
Resistance Level
$34.33
Current Trend
Strong Uptrend
Technical data as of
Aug 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
62.96
Wall Street Target
$35.00
(+2.9%)
Revenue Growth (YoY)
18.6%
Profit Margin
-31.2%
Valuation Premium vs History
+20.2% premium
PE vs Historical
63.0 vs 36.3
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+20.2%
(market-implied from PE analysis)
1-Year Target
$40.87
(+20%)
2-Year Target
$49.12
(+45%)
3-Year Target
$59.05
(+74%)
3-Yr Target (if PE normalizes)
(PE: 63→36)
PE COMPRESSION
$34.04
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 63.0, Growth: 200.0%)
$114.75
(+238%)
Base:
(SPY PE: 20.7, Growth: 200.0%)
$37.78
(+11%)
Bear:
(PE: 17.6, Growth: 200.0%)
$32.11
(-6%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (189x PE), but valuation improves significantly next year (63x PE) as earnings recover.
Forward PE: 188.68 | Forward EPS (Implied): $0.18
Bull Case
$40.89
(+21%)
Analyst growth 15.0%, PE expands to 198.1
Base Case
$33.86
(0%)
Market implied 0.0%, PE stable at 188.7
Bear Case
$25.90
(-24%)
Severe decline -15.0%, PE contracts to 169.8
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: August 04, 2026 10:42 AM ET
Data refreshes hourly during market hours. Next update: 11:42 AM
Data refreshes hourly during market hours. Next update: 11:42 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SMTI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$477 | 50 HOLD |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$87 | 52 HOLD |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$186 | 54 HOLD |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
13 analysts |
$405 | 55 HOLD |
|
COO
The Cooper Companies, Inc |
BUY
19 analysts |
$81 | 59 HOLD |
